Abstract:Transmissible spongiform encephalopathies are a class of fatal neurodegenerative diseases linked to the prion protein. The prion protein normally exists in a soluble, globular state (PrP(C)) that appears to participate in copper metabolism in the central nervous system and/or signal transduction. Infection or disease occurs when an alternatively folded form of the prion protein (PrP(Sc)) converts soluble and predominantly alpha-helical PrP(C) into aggregates rich in beta-structure. The structurally disordered N-terminus adopts beta-structure upon conversion to PrP(Sc) at low pH. Chemical chaperones, such as trimethylamine N-oxide (TMAO), can prevent formation of PrP(Sc) in scrapie-infected mouse neuroblastoma cells [Tatzelt, J., et al. (1996) EMBO J. 15, 6363-6373]. To explore the mechanism of TMAO protection of PrP(C) at the atomic level, molecular dynamics simulations were performed under conditions normally leading to conversion (low pH) with and without 1 M TMAO. In PrP(C) simulations at low pH, the helix content drops and the N-terminus is brought into the small native beta-sheet, yielding a PrP(Sc)-like state. Addition of 1 M TMAO leads to a decreased radius of gyration, a greater number of protein-protein hydrogen bonds, and a greater number of tertiary contacts due to the N-terminus forming an Omega-loop and packing against the structured core of the protein, not due to an increase in the level of extended structure as with the PrP(C) to PrP(Sc) simulation. In simulations beginning with the "PrP(Sc)-like" structure (derived from PrP(C) simulated at low pH in pure water) in 1 M TMAO, similar structural reorganization at the N-terminus occurred, disrupting the extended sheet. The mechanism of protection by TMAO appears to be exclusionary in nature, consistent with previous theoretical and experimental studies. The TMAO-induced N-terminal conformational change prevents residues that are important in the conversion of PrP(C) to PrP(Sc) from assuming extended sheet structure at low pH.

Osmolyte trimethylamine N-oxide converts recombinant alpha-helical prion protein to its soluble beta-structured form at high temperature

Preventing misfolding of the prion protein by trimethylamine N-oxide

Comparison of the Unfolding and Oligomerization of Human Prion Protein under Acidic and Neutral Environments by Molecular Dynamics Simulations

Entropic Stabilization of Proteins by TMAO

When does TMAO fold a polymer chain and urea unfold it?

Thermal Denaturing of Mutant Lysozyme with Both the OPLSAA and the CHARMM Force Fields

Inhibition of amyloid fibril formation of hen egg white lysozyme by trimethylamine N-oxide at low pH

Oligomerization of Yeast Prion Sup35NM

Structural and Dynamic Properties of the Human Prion Protein.

TMAO to the rescue of pathogenic protein variants

The gut metabolite, trimethylamine N-oxide inhibits protein folding by affecting cis-trans isomerization and induces cell cycle arrest

The protein-stabilizing effects of TMAO in aqueous and non-aqueous conditions

Microscopic insights into the protein-stabilizing effect of trimethylamine N-oxide (TMAO)

Temperature-Dependent Structural Variability of Prion Protein Amyloid Fibrils

Conformational changes of human neuronal tau during thermal and guanidine-HCL denaturation

Trimethylamine-N-oxide switches from stabilizing nature: A mechanistic outlook through experimental techniques and molecular dynamics simulation

Quantitative Study of the Oligomerization of Yeast Prion Sup35NM Proteins.

The alpha-to-beta conformational transition of Alzheimer's Abeta-(1-42) peptide in aqueous media is reversible: a step by step conformational analysis suggests the location of beta conformation seeding

Unfolding Mechanism and Fibril Formation Propensity of Human Prion Protein in the Presence of Molecular Crowding Agents

Shaking alone induces de novo conversion of recombinant prion proteins to β-sheet rich oligomers and fibrils

Trimethylamine N-Oxide (TMAO): a Unique Counteracting Osmolyte?